MYCN and neuroblastoma: One important therapeutic issue is restoring drug sensitivity, because neuroblastoma-derived cells maintain competent mitochondrial apoptotic signalling [5] and are dependent on these pathways for response to various cellular stressors such as N-Myc overexpression or cytotoxic agents [6, 7].